These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 5796373)

  • 1. The positive and negative inotropic effects of quinidine.
    Fuchs F; Gertz EW; Briggs FN
    J Gen Physiol; 1969 Aug; 54(2):286-7. PubMed ID: 5796373
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationship of intracellular depolarization rates and contractility in the dog ventricle in situ: effects of positive and negative inotropic agents.
    Pruett JK; Woods EF
    J Pharmacol Exp Ther; 1967 Jul; 157(1):1-7. PubMed ID: 6029486
    [No Abstract]   [Full Text] [Related]  

  • 3. Quinidine effects on heart muscle. Positive and negative inotropy in relation to depression of the cardiac sarcotubular calcium pump.
    Kennedy BL
    J Gen Physiol; 1969 Aug; 54(2):285-6. PubMed ID: 5796372
    [No Abstract]   [Full Text] [Related]  

  • 4. Action potential, membrane currents and force of contraction in mammalian heart muscle fibers treated with quinidine.
    Nawrath H
    J Pharmacol Exp Ther; 1981 Jan; 216(1):176-82. PubMed ID: 7452504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interference of quinidine on the inotropic effect of ouabain].
    Rovere AA; Grin JJ
    Acta Physiol Lat Am; 1969; 19(3):262-8. PubMed ID: 5374280
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms of the atrium-specific positive inotropic activities of quinidine- and atropine-like agents in rats.
    Deng XF; Mulay S; Chemtob S; Varma DR
    J Pharmacol Exp Ther; 1997 Apr; 281(1):322-9. PubMed ID: 9103513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purging action of quinidine. Potentiation of contraction coupling to basic electric rhythms.
    Burchell HB
    Circulation; 1967 Aug; 36(2):173-4. PubMed ID: 4952654
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of quinidine and its chiral isolates on erg-1sm potassium current and correlation with gastrointestinal augmentation.
    Cvetanovic I; Lin C; Ranade V; Keshavarzian A; Somberg J
    Am J Ther; 2007; 14(3):269-76. PubMed ID: 17515703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Decreased sodium conductance of the cardiomyocyte membrane: the cause of the negative inotropic action of quinidine-like anti-arrhythmia agents].
    Nesterenko VV; Rozenshtraukh LV
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):41-51. PubMed ID: 6291554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of interaction between digoxin and quinidine in cultured heart cells.
    Horowitz JD; Barry WH; Smith TW
    J Pharmacol Exp Ther; 1982 Mar; 220(3):488-93. PubMed ID: 7062261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressant effects of drugs used in myotonia therapy.
    Courtney KR
    Proc West Pharmacol Soc; 1982; 25():159-61. PubMed ID: 6289335
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of quinidine on the cardiac-glycoside sensitivity of guinea-pig and rat heart.
    Kim DH; Akera T; Brody TM
    J Pharmacol Exp Ther; 1981 Jun; 217(3):559-65. PubMed ID: 7229993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of quinidine on the inotropic effect of cardiac glycosides in isolated cardiac muscle.
    Hair TL; Taubert KA
    Proc West Pharmacol Soc; 1983; 26():313-6. PubMed ID: 6889359
    [No Abstract]   [Full Text] [Related]  

  • 14. Positive inotropic effects of the calcium sensitizer CGP 48506 in failing human myocardium.
    Neumann J; Eschenhagen T; Grupp IL; Haverich A; Herzig JW; Hirt S; Kalmár P; Schmitz W; Scholz H; Stein B; Wenzlaff H; Zimmermann N
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1579-85. PubMed ID: 8667226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of negative inotropic and antiarrhythmic effects of class 1 antiarrhythmic drugs.
    Nawada T; Tanaka Y; Hirai S; Hisatome I; Hasegawa J; Kotake H; Mashiba H
    Int J Clin Pharmacol Ther; 1994 Jul; 32(7):347-55. PubMed ID: 7952796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual effects of quercetin on contraction in cardiac and skeletal muscle preparations.
    Apisariyakul A; Chaichana N; Takemura H
    Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):129-38. PubMed ID: 10850376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative myocardial depressant and anti-arrhythmic properties of d-propranolol, dl-propranolol and quinidine.
    Parmley WW; Braunwald E
    J Pharmacol Exp Ther; 1967 Oct; 158(1):11-21. PubMed ID: 6054071
    [No Abstract]   [Full Text] [Related]  

  • 18. Time course of the electrophysiological effects of quinidine on canine cardiac Purkinje fibers: concentration dependence and comparison with lidocaine and disopyramide.
    Nattel S; Bailey JC
    J Pharmacol Exp Ther; 1983 Apr; 225(1):176-80. PubMed ID: 6834270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ouabain-induced increase in Na content of cultured myocardial cells by quinidine and procainamide.
    Goshima K; Wakabayashi S
    J Pharmacol Exp Ther; 1983 Jan; 224(1):239-46. PubMed ID: 6294280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular mechanism of the negative inotropic effect induced by alpha1-adrenoceptor stimulation in mouse myocardium.
    Hirano S; Kusakari Y; O-Uchi J; Morimoto S; Kawai M; Hongo K; Kurihara S
    J Physiol Sci; 2006 Aug; 56(4):297-304. PubMed ID: 16884559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.